Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

download Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

of 4

Transcript of Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

  • 8/6/2019 Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

    1/4

    Male circumcision should be promoted in developing countries as a major means of HIV

    prevention.

    Felipe Meja

    Master of Science in International Health

    Reproductive Health and HIV/AIDS

    Introduction

    According to UNAIDS for its AIDS epidemic 2009 report, the total number of people living with HIV

    in 2008 was 33.4 million, among them 15.7 million of are women and 2.1 million children under 15years old. The same data reported 2.7 million new infections due to HIV in 2008 and 2.0 million deaths

    due to AIDS. Sub-Saharan Africa has the largest amount of people living with HIV accounting for 22.4

    million with an adult prevalence of 5.2%. Of over 7400 new HIV infections a day in 2008, 97% are in

    low- and middle-income countries, 6200 are in adults (15-49 years old), 48% women. Comparing to2001, there has been a reduction in the total new cases by 0.5 million.i Even considering that the new

    cases have decreased over the years between 2001 and 2008, HIV/AIDS remains as an important cause

    of mortality and morbidity in the world especially in the poorest regions. Due to its continue spread,developing new methods or extending existing ones which can protect large populationa against new

    infections are still urgent.

    Male circumcision has been analyzed for the past years as a possible procedure to protect men on HIV

    infection. Indeed, three studies made in South Africaii, Kenyaiiiand Ugandaiv have shown that it reduces

    the probability of getting infected by 50% making it as a possible tool for a national policy indeveloping countries. However, male circumcision programs depend on different factors which must be

    under analysis according to particular cases.

    Efforts similar to the mentioned above has been carried out previously for antiretroviral treatments,showing that the integration with national policies, the civil society, all non-governmental

    organizations and other different stakeholders as well as qualified health facilities and medical products

    supply are required to achieve success. It is also important to stress that in non-endemic regions, malecircumcision programs may not be significantly. However, for endemic places as it is in Sub Saharan

    Africa, the possible results may be greater. It was estimated for 2007 that in rural KwaZulu-Natal,

    South Africa, male circumcision would prevent an estimated 35 000 new HIV infections in the 25million men with the previous knowledge that most of them were circumcised.v

    Peoples acceptability:

    In most of the countries in Sub Saharan Africa, male circumcision is common practice. Some studiesvi

    have shown that 61% of men are willing to be circumcised and 81% of couples are willing to

    circumcise their male children. However, for regions where this is an uncommon practice, thisintervention has more challenges and ethical in regarding to social, cultural and religious issues must be

    addressed carefully.

    Male circumcision Prevalence

    The prevalence of male circumcision does not necessarily depend on the presence of religious activitiesor a specific cultural basis as it is in some countries in Africa. Indeed, it does not depend also on

    differences between developed and not developed countries. In USA more than 80% of new born were

    circumcised in late 1970, 48% Canada and 24% UK. Yet USA has one of the highest prevalence of

  • 8/6/2019 Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

    2/4

    male circumcision as a routine procedure with 84 to 89% in the 80s. vii In developing countries where

    male circumcision is a common practice for social or non social reasons, it is important to establish

    what the prevalence is in order to set a base line for a future intervention.

    Information, Communication, Education (IEC):

    How to disseminate the information among the targeted people and integrate it to the other preventiveprograms? Considering that the protective effect has been estimated as 50% as mentioned above, the

    messages which want to get attention for the future circumcised men must make clear that male

    circumcision is not always effective. So, it implies that the education among the population of interestmust be aware of other preventions tools and behaviors such as condoms, non promiscuous behaviors,

    etc. WHO and UNAIDS must focus on the messages that recent circumcised men should restart sexual

    activity only after six weeks.viii Should the information only go straight to men or should involve also

    their partners? Should women be aware about male circumcision effectiveness?

    Moral Hazard

    In this concern, it is possible to question: will the knowledge of being circumcised reduce the

    willingness to use condom? Will it increase the probability of risky behaviors? In the trial carried out in

    Ugandaix there is no evidence which suggest such moral hazard. Although, male circumcisioncounseling must consider this possible effect in any case.

    Religious and cultural issues:

    In places where communities practice male circumcision among their believes and who are reluctant to

    HIV/SIDA campaigns, male circumcision may be a possible bridge of dialogue to persuade them and to

    integrate them into safer practices and achieve cultural and community acceptance.

    When to circumcise? Whom?

    Some trials show that the effectiveness of male circumcision decreases with agex, others have shown

    that male circumcision in new born or neonatal is safer and has less cost comparing to adolescent and

    adultsxi. So, for male circumcision program seems to be better to do it at this age in places where thisprocedure is not common especially considering that there are less risks associated to circumcisions

    made in health facilities than in non clinical settingsxii. Looking at this point, this kind of intervention

    seems to be similar to vaccination where the risk group is not already exposed. It is also important to

    investigate whether the male circumcisions made by trained health professionals and people from thecommunities have the same effectiveness.

    Male circumcisions risks:

    As it was mentioned, possible complications in male circumcision procedures can come out depending

    on: age of the patient, training of the personnel who perform it , instruments used and quality assuranceof the procedures such as sterility among others. In the trial made in South Africa, 3.8% of the men

    circumcised by trained personnel developed complications afterwards.xiii Male circumcision which

    takes place in traditional areas where it is a common practice due to social or religious factors, as inAfrica, are related to high incidence of complications.xiv This is similar to the complications reported

    for developed countries where male circumcision is common.xv

  • 8/6/2019 Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

    3/4

    Integration with other programs/procedures/products:

    There is no doubt that in case a male circumcision program is implemented; it must be parallel with

    other prevention activities such as condom promotion and delivery, awareness campaigns, counselingfamily planning, HIV tests, etc.

    Vertical vs Horizontal approach:

    Should an intervention like this require a vertical approach as it has been done for HIV/AIDS program

    interventions? Or is it possible to integrate it into the neonatal care routine activities? These questionsshould be formulated along with the next consideration:

    Although achieving high rates of circumcision might be beneficial, it should not be at the cost of other

    disease prevention strategieseg, antenatal care, malaria control, or nutrition. Since an internationallyagreed-upon public health goal is for all women to give birth in health facilities, offering male

    circumcision to babies in clinics would at least not divert national resources from current efforts to

    build systems, and might be a strategy that has multiple benefits xvi

    It also has to be studied how many surgeries are needed to prevent one new case of HIV positive which

    depends on contextual factors as well as epidemiological. How cost effective for specific settingswould have an intervention such as this one?

    Conclusion

    Even considering the probable beneficial effects of male circumcision to prevent new cases of HIV,

    public health authorities must consider the social cultural context of the place under interest, the

    resources available, the trained available personnel, the male willingness, the possible clinicalcomplications and the respective awareness among the population, political and social implications.

    The question ultimately is: Is anything acceptable if it leads to a successful result?

  • 8/6/2019 Male Circumcision. Felipe Mejia. Reproductive Health and HIV Advance Module.

    4/4

    i Unaids. (2009). AIDS epidemic update December 2009. Available:

    http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp . Last accessed 25 Feb

    2010.ii Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of

    male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2: e298.iii Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a

    randomised controlled trial. Lancet 2007; 369: 64356.iv Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised

    trial. Lancet 2007; 369: 65766.v Welz T, Hosegood V, Jaffar S, Batzing-Feigenbaum J, Herbst K, Newell ML. Continued very high prevalence of HIV

    infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS 2007 Jul 11;21(11):1467-72.vi Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a

    review. AIDS Behavior 2007;11(3):341-355.vii Bonner K. Male circumcision as an HIV control strategy: Not a Natural Condom. Reproductive Health Matters, 2001 ;

    9, 18, pp. 143-155.viii WHO/UNAIDS Male Circumcision for HIV Prevention: Research Implications for Policy and Programming

    WHO/UNAIDS Technical Consultation 68 March 2007 Conclusions and Recommendations (Excerpts). Reproductive

    Health Matters 2007;15(29): pp. 1114ix Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomisedtrial. Lancet 2007; 369: 65766.x Bonner K. Male circumcision as an HIV control strategy: Not a Natural Condom. Reproductive Health Matters, 2001 ;

    9, 18, pp. 143-155.xi Schoen EJ, Colby CJ, To TT. Cost analysis of neonatal circumcision in a large health maintenance organization. J Urol

    2006; 175:111115.xii Bonner K. Male circumcision as an HIV control strategy: Not a Natural Condom. Reproductive Health Matters, 2001 ;

    9, 18, pp. 143-155.xiii Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of

    male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2: e298.xiv Sharif R Sawires, Shari L Dworkin, Agns Fiamma, Dean Peacock, Greg Szekeres, Thomas J Coates Male circumcisionand HIV/AIDS: challenges and opportunities The Lancet, Volume 369, Issue 9562, 24 February 2007-2 March 2007, Pages

    708-713xv Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a

    randomised controlled trial. Lancet 2007; 369: 64356.xvi Sharif R Sawires, Shari L Dworkin, Agns Fiamma, Dean Peacock, Greg Szekeres, Thomas J Coates Male circumcision

    and HIV/AIDS: challenges and opportunities The Lancet, Volume 369, Issue 9562, 24 February 2007-2 March 2007, Pages708-713